TASHKENT -- COVID-19-related aid from the United States to Central Asia shows no signs of slackening.
The US government Monday (October 25) delivered 273,780 doses of the Pfizer vaccine to Uzbekistan, one week after the October 18 arrival of a shipment of 526,500 Pfizer doses.
Uzbekistan also received more than 1.2 million Pfizer doses in September and more than 3 million Moderna doses in July from the United States.
"Our vaccines do not come with strings attached," said US Ambassador to Uzbekistan Daniel Rosenblum, according to the embassy. "We are sharing these vaccines to save lives and to help end the pandemic."
The United States is donating 1.1 billion COVID-19 vaccines worldwide -- of which it has already delivered more than 200 million doses -- through the COVID-19 Vaccine Global Access (COVAX).
COVAX also has delivered about 1.6 million doses of AstraZeneca to Uzbekistan in multiple shipments, partially funded by the US government.
The United States is the largest donor to COVAX.
Meanwhile, the US Agency for International Development (USAID) has worked closely with Uzbekistan throughout the pandemic on improving testing for, treatment of and response to COVID-19.
PPE for Bishkek hospitals
In similar news in neighbouring Kyrgyzstan, USAID on October 19 delivered personal protective equipment (PPE) and medical supplies to two hospitals in Bishkek.
"The National Hospital and the Republican Infectious Diseases Hospital received 19,000 pairs of disposable gloves, 5,000 respirators, 960 safety goggles, 10,000 anti-slip shoe covers, along with 50 pacemakers for patient care," the US Embassy in Bishkek said in a statement.
The support was critical in the fight against the pandemic, said Toktobay Maanayev, manager of the National Hospital.
And in July, USAID gave modern equipment and supplies to five Kyrgyz hospitals burdened with a heavy COVID-19 caseload.